Patents by Inventor Seong Gyu KO

Seong Gyu KO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11666619
    Abstract: Provided are a composition for treating atopic dermatitis including an herbal medicine mixed extract, and more particularly, a pharmaceutical composition, a food composition, a quasi-drug composition, and a cosmetic composition for preventing or treating atopic dermatitis, each composition including a mixed extract of Phellodendri Cortex, Schizonepetae Spica, Sophorae Radix, Glycyrrhizae Radix, Liriopis Tuber, and Radix Rehmanniae Exsiccate or a fraction thereof, and a method of treating atopic dermatitis using the pharmaceutical composition. The complex herbal medicine extract of the present invention may prevent, ameliorate, and treat atopic dermatitis to a degree similar or superior to those of the known therapeutic agents for atopic dermatitis.
    Type: Grant
    Filed: September 1, 2017
    Date of Patent: June 6, 2023
    Assignee: K-LAB Corp.
    Inventors: Seong-Gyu Ko, Inhwa Choi, Younghee Yun, Se Hyang Hong, Jin Mo Ku
  • Publication number: 20220323526
    Abstract: The present invention relates to a composition for preventing or treating cancer comprising a mixed extract of Angelica gigas, Aconitum carmichaeli Debeaux, and Zingiber officinale Roscoe as an active ingredient, more particularly to a pharmaceutical composition, a food composition, and a feed composition for preventing or treating cancer including a mixed extract of Angelica gigas, Aconitum carmichaeli Debeaux, and Zingiber officinale Roscoe as an active ingredient; a method for preventing or treating cancer comprising a step of administering the pharmaceutical composition; and a use for preventing or treating cancer. Angelica gigas, Aconitum carmichaeli Debeaux, or Zingiber officinale Roscoe of the present invention exhibits excellent cancer treatment effects, and therefore can be included in a pharmaceutical composition or a food as an active ingredient to be used in development of cancer treatment or amelioration agents and the like.
    Type: Application
    Filed: August 28, 2020
    Publication date: October 13, 2022
    Inventor: Seong-Gyu Ko
  • Publication number: 20220175862
    Abstract: Provided are a pharmaceutical composition and a method for preventing or treating hypercholesterolemia, the pharmaceutical composition including a Platycodon grandiflorum extract or Platycodin D derived therefrom, and a statin-class drug as active ingredients. Also disclosed is a method of increasing expression of low-density lipoprotein receptor, the method including the step of treating hepatocytes in vitro with a Platycodon grandiflorum extract or Platycodin D derived therefrom.
    Type: Application
    Filed: February 3, 2020
    Publication date: June 9, 2022
    Inventor: Seong-Gyu Ko
  • Patent number: 11351218
    Abstract: The present invention relates to an extract of at least any one selected from the group consisting of Platycodon grandiflorum, Scutellaria baicalensis, Phellodendron amurense Ruprecht, and Rubus coreanus, or a fraction thereof; and to a use of the same for prevention, improvement, or treatment of glioblastoma multiforme.
    Type: Grant
    Filed: February 12, 2020
    Date of Patent: June 7, 2022
    Assignee: University-Industry Cooperation Group of Kyung Hee University
    Inventor: Seong-Gyu Ko
  • Publication number: 20200345802
    Abstract: The present invention relates to an extract of at least any one selected from the group consisting of Platycodon grandiflorum, Scutellaria baicalensis, Phellodendron amurense Ruprecht, and Rubus coreanus, or a fraction thereof; and to a use of the same for prevention, improvement, or treatment of glioblastoma multiforme.
    Type: Application
    Filed: February 12, 2020
    Publication date: November 5, 2020
    Inventor: Seong-Gyu Ko
  • Patent number: 10568922
    Abstract: The present invention relates to a composition containing, as an active ingredient, a mixed extract of Astragalus membranaceus, Angelica gigas, and Trichosanthes kirilowii, for preventing or treating cancer. The mixed extract of Astragalus membranaceus, Angelica gigas, and Trichosanthes kirilowii according to the present invention does not impact normal cell growth, while having an anticancer effect which specifically inhibits the proliferation of cancer cells, and an excellent effect of inhibiting metastasis of cancer cells, and thus can be useful in preventing or treating cancer and supplementing cancer treatment.
    Type: Grant
    Filed: January 29, 2018
    Date of Patent: February 25, 2020
    Assignee: JAEIN RESEARCH AND PHARMACY
    Inventors: Seong Gyu Ko, Sung Gook Cho, Youn Kyoung Choi, Hee Sun Yim
  • Publication number: 20190336559
    Abstract: Provided are a composition for treating atopic dermatitis including an herbal medicine mixed extract, and more particularly, a pharmaceutical composition, a food composition, a quasi-drug composition, and a cosmetic composition for preventing or treating atopic dermatitis, each composition including a mixed extract of Phellodendri Cortex, Schizonepetae Spica, Sophorae Radix, Glycyrrhizae Radix, Liriopis Tuber, and Radix Rehmanniae Exsiccate or a fraction thereof, and a method of treating atopic dermatitis using the pharmaceutical composition. The complex herbal medicine extract of the present invention may prevent, ameliorate, and treat atopic dermatitis to a degree similar or superior to those of the known therapeutic agents for atopic dermatitis.
    Type: Application
    Filed: September 1, 2017
    Publication date: November 7, 2019
    Inventors: Seong-Gyu Ko, Inhwa Choi, Younghee Yun, Se Hyang Hong, Jin Mo Ku
  • Publication number: 20180169168
    Abstract: The present invention relates to a composition containing, as an active ingredient, a mixed extract of Astragalus membranaceus, Angelica gigas, and Trichosanthes kirilowii, for preventing or treating cancer. The mixed extract of Astragalus membranaceus, Angelica gigas, and Trichosanthes kirilowii according to the present invention does not impact normal cell growth, while having an anticancer effect which specifically inhibits the proliferation of cancer cells, and an excellent effect of inhibiting metastasis of cancer cells, and thus can be useful in preventing or treating cancer and supplementing cancer treatment.
    Type: Application
    Filed: January 29, 2018
    Publication date: June 21, 2018
    Inventors: Seong Gyu KO, Sung Gook CHO, Youn Kyoung CHOI, Hee Sun YIM
  • Publication number: 20160243180
    Abstract: An embodiments of the invention relates to a composition containing, as an active ingredient, a mixed extract of Astragalus membranaceus, Angelica gigas, and Trichosanthes kirilowii, for preventing or treating cancer. The mixed extract of Astragalus membranaceus, Angelica gigas, and Trichosanthes kirilowii according to this embodiment of the invention does not impact normal cell growth, while having an anticancer effect which specifically inhibits the proliferation of cancer cells, and an excellent effect of inhibiting metastasis of cancer cells, and thus can be useful in preventing or treating cancer and supplementing cancer treatment.
    Type: Application
    Filed: June 11, 2014
    Publication date: August 25, 2016
    Inventors: Seong Gyu KO, Sung Gook CHO, Youn Kyoung CHOI, Hee Sun YIM